UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Bukwang to change clinical design for Covid-19 drug candidate
Bukwang Pharm said it would modify the clinical trial design on Levovir (cl...
by Kim Chan-hyuk
|
2020-06-30 13:18
라인
Samsung Bioepis’ drug to join bevacizumab biosimilar competition in Europe
Samsung Bioepis’ Aybintio is expected to heat up biosimilars competition re...
by Kim Chan hyuk
|
2020-06-29 16:08
라인
Vivozon to start P3b trial of nonnarcotic analgesics in US
Vivozon said that it has started recruiting patients for phase 3b clinical ...
by Lee Han-soo
|
2020-06-26 17:13
라인
Helixmith pushes ahead with P3-2 trial for neuropathic pain treatment
Helixmith said that it has started its phase 3-2 trial for its gene therapy...
by Lee Han-soo
|
2020-06-26 16:38
라인
Celltrion tops pharmaceutical brand reputation in June
Celltrion ranked the first in the local brand reputation of listed pharmace...
by Park Gi-taek
|
2020-06-26 15:23
라인
10 more Korean drugmakers nestle in Boston to enter US market
Ten Korean pharmaceutical companies have additionally settled in the Cambri...
by Kim chan-hyuk
|
2020-06-26 14:12
라인
Alteogen signs $3.8-billion tech transfer deal with a global pharma
Alteogen has signed a $3.87 billion tech transfer contract with a global ph...
by Shim Hyun-tai
|
2020-06-25 16:19
라인
‘Use NEWS score system to detect high-risk Covid-19 patients early’
To reduce deaths caused by Covid-19 without treatment and vaccine, it is es...
by Song Soo-youn
|
2020-06-25 15:07
라인
Hanmi, Novartis in patent dispute over diabetes drug
A court is to decide on the legal dispute between Hanmi Pharmaceutical and ...
by Kim Yun-mi
|
2020-06-25 13:59
라인
Hanmi Science Presents 6 Great Visions for Post COVID-19
Hanmi Science with the gene of 'Innovation' presented six great vis...
by Lee Han-soo
|
2020-06-24 18:02
라인
GSK sure about Dovato’s changing HIV treatment paradigm
GSK is pioneering a new field in the human immunodeficiency virus (HIV) mar...
by Lee Han-soo
|
2020-06-24 12:11
라인
Hanmi to sell prostatism drug in Japan
Hanmi Pharmaceutical said Tuesday that it would release 2.5- and 5- milligr...
by Shim Hyun-tai
|
2020-06-23 18:17
라인
[News Focus] Pfizer Korea's restructuring enters into last-minute tug-of-war with union
The unionized workers of Upjohn Korea, a spinoff of Pfizer Korea's esta...
by Lee Han-soo
|
2020-06-23 16:51
라인
Labor-management dispute runs deep at MSD Korea
The conflict between unionized workers and management at MSD Korea is inten...
by Kim Yun-mi
|
2020-06-23 12:06
라인
‘Pfizer’s Vyndaqel, Vyndamax do not deserve rare disease pricing’
Pfizer’s Vyndaqel and Vyndamax -- containing tafamidis to treat cardiomyopa...
by Kim Yun-mi
|
2020-06-22 17:19
라인
New diabetes drug Steglatro fails to prove cardiovascular benefit
Steglatro (ingredient: ertugliflozin), the latecomer sodium-glucose co-tran...
by Kim Yun-mi
|
2020-06-19 14:55
라인
Yuyu to export SD Biosensor's Covid-19 test kit
Yuyu Pharmaceutical and SD Biosensor said they would cooperate in exporting...
by Lee Han-soo
|
2020-06-19 14:48
라인
HK inno.N nabs FDA nod for trial of gastric acid blocker
HK inno.N, formerly known as CJ Healthcare, said that the U.S. Food and Dru...
by Lee Han-soo
|
2020-06-18 17:39
라인
AZ’s Imfinzi wins extra indication for small-cell lung cancer
AstraZeneca’s immunotherapy Imfinzi (ingredient: durvalumab) has obtained l...
by Kim Yun-mi
|
2020-06-18 15:55
라인
5 key factors in successful secondary packaging and device assembly strategy
In his book The 7 Habits of Highly Effective People, Dr. Steven R. Covey of...
by Lee Han-soo
|
2020-06-18 15:52
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top